BUSINESS & REGULATION
C&G Therapy? That’ll Do NICEly
03/19/2019 | James Strachan
Nick Crabb explains the UK’s health technology assessment agency's (NICE's) approach to cell and gene therapies.
DISCOVERY & DEVELOPMENT
The Color of Chirality
03/19/2019 | Maryam Mahdi
Forty years ago, it was theorized that chirality had a color composition that could be measured… and finally the theory has been proven.
DISCOVERY & DEVELOPMENT
Perusing the Pipeline
03/19/2019 | James Strachan
With cell and gene therapies being all the rage, we take a peek at some of the advanced therapies coming down the pipe.
BUSINESS & REGULATION
Animal-Free; Risk-Free
03/18/2019 | Aaron Schieving
If you or your supplier are working with animal-derived components, you run the risk of exposing patients to dangerous contaminations.
 
Click below for the latest print issue
Download the PDF
 
Passionate. Driven. Impactful.

The Translational Scientist sits at the leading edge of bench-to-bedside research, celebrating translation today – and exploring the inside track on the innovations set to revolutionize tomorrow...

Read The Newsletter
 
All Aboard the Seed Train?

Have you caught up with Gene and Eva’s latest (mis)adventure?

Read More
 
White Papers
Theory and practice of Differential Scanning Calorimetry
06/05/2018 | Contributed by Malvern Panalytical
The benefits and specifics of DSC.
Use of SEC in the Analysis of Plasmid DNA
06/05/2018 | Contributed by Malvern Panalytical
In the biopharmaceutical industry, plasmid DNA is used as both a raw material and active ingredient in vaccines.
 
Product Profile
IPS Technologies Tours at INTERPHEX

Hear from industry leaders on what Pharma 4.0 means for technological advances in today's pharmaceutical market, as they showcase their most innovative and best-performing equipment, processes, and technologies. Whether you are planning for a major investment or need to upgrade existing operations, the IPS Technologies Tours are the perfect opportunity to learn, share, and be inspired.

Read More
 
Special Promotions
Nemera’s multidose eye dropper Novelia® approved for Santen’s Cosopt®, for Glaucoma treatments in 29 European countries

Cosopt® is indicated in the treatment of elevated IOP in patients with open-angle glaucoma or pseudoexfoliative glaucoma when topical beta-blocker monotherapy is not sufficient. Nemera’s preservative-free multi-dose bottles for Cosopt® feature a low squeeze force and smooth bottle, to reduce the pressure required to dispense a drop and improve ease-of-use, particularly for the elderly.

Read More
 
At the Cutting-Edge of Pharma Analytics

Analytical technology and expertise is essential for pharmaceutical development, from routine quality control to improving research and development through crystallization and characterization experiments. MilliporeSigma takes the importance of analytical science in pharma very seriously and has set up a specialized internal solutions provider for tough analytical challenges: Site Management Analytics.

Read More
 

The Right Choices in Biomanufacturing

 

Single use? Stainless steel? Continuous bioprocessing? Experts share their advice to help you choose the best path for your product. Pall can help you to develop your monoclonal antibody or recombinant protein processing requirements into a simplified, streamlined, integrated solution that will speed you to market and reduce cost of goods.

Read More
 
Events

Be it a large congress at a huge venue or an expert meeting that fits around a table, these events are a fantastic way to network and educate yourself on the latest developments in the industry – so why not take a look at our list of upcoming events?

More Information